Biomedical innovation for incurable neurological disorders
NEW: COFEPRIS approval of cerebral palsy protocol
Repairing the Brain
Our technology and its related protocols are a new approach to the treatment of neurological diseases such as cerebral palsy, stroke, and traumatic brain injuries.
J. Roberto Trujillo, M.D., and Sc.D., from Harvard University is our founder, Chairman, and CEO. Dr. Trujillo has worked in clinical and basic neuroscience research for over 25 years and has spent the last 10 years in translation research for brain regeneration technology.
Our transformational medical technology is designed to stimulate brain regeneration, restoring the structure of the nervous system.
Our neural tissue engineering technology uses a combination of instantaneous magnetic fields and targeted radiofrequency (RF) waves. The protocol is non-invasive and safe with no known side effects.
Mexican regulatory authority COFEPRIS has acknowledged the results of our clinical trial and approved our protocol for cerebral palsy.
To know more about our clinical trial, please check a full description at ClinicalTrials.gov
We have a well-established clinical center in Monterrey, Mexico, in compliance with the FDA rules of “Good Clinical Practice” (GCP).